HUNT RONALD — SEC insider filings

SEC reporting owner CIK 1247851. 38 insider filings on record with FilingPulse; latest filed 2026-11-05.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2021-05-07 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Harpoon Therapeutics, Inc. (HARP)Director, 10% owner134 legs · 1,788,794 sh · $13,999,998—27
Rallybio Corp (RLYB)Director122 legs · 307,692 sh · $3,999,996—22
Iterum Therapeutics plc (ITRM)Director13——26

Insider filings — HUNT RONALD

FiledFormIssuerReported transactionsSource
2026-11-054Rallybio Corp (RLYB)Option exercise (M): 14,305 @ $4.45 · Option exercise (M): 14,305 (derivative) @ $3.60EDGAR
2026-11-024Rallybio Corp (RLYB)Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 9,196 @ $7.60 · Option exercise (M): 2,062 @ $15.28 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 9,196 (derivative) @ $5.60 · Option exercise (M): 2,062 (derivative) @ $0EDGAR
2026-02-204Rallybio Corp (RLYB)Grant/award (A): 14,305 (derivative) @ $3.60EDGAR
2025-05-154Rallybio Corp (RLYB)Grant/award (A): 28,500 (derivative) @ $0EDGAR
2025-01-234Iterum Therapeutics plc (ITRM)Other (J) @ $2,208,000 · Other (J) @ $792,000EDGAR
2025-01-064Rallybio Corp (RLYB)Grant/award (A): 73,571 (derivative) @ $0.70EDGAR
2024-08-124Iterum Therapeutics plc (ITRM)Option exercise (M): 182,453 · Option exercise (M): 65,481 · Option exercise (M): 364,906 (derivative) @ $0 · Option exercise (M): 182,453 (derivative) · Option exercise (M): 182,453 (derivative) · Option exercise (M): 130,962 (derivative) @ $0 · +2 moreEDGAR
2024-05-174Rallybio Corp (RLYB)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2024-03-114Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 424 @ $0 · Disposition to issuer (D): 13,224 · Disposition to issuer (D): 1,463,386 · Disposition to issuer (D): 395,783 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 299,430 (derivative) · +6 moreEDGAR
2024-01-044Rallybio Corp (RLYB)Grant/award (A): 29,096 (derivative) @ $1.77EDGAR
2024-01-034Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 1,072 @ $0EDGAR
2023-11-284Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 5,000 @ $0EDGAR
2023-10-274Harpoon Therapeutics, Inc. (HARP)Purchase (P): 1,372,000 · Purchase (P): 171,500 · Purchase (P): 686,000 (derivative) · Purchase (P): 85,750 (derivative)EDGAR
2023-10-024Iterum Therapeutics plc (ITRM)Option exercise (M): 5,479 · Option exercise (M): 5,479 (derivative) @ $0EDGAR
2023-10-024Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 3,035 @ $0EDGAR
2023-07-064Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 18,656 @ $0EDGAR
2023-07-034Iterum Therapeutics plc (ITRM)Option exercise (M): 2,796 · Option exercise (M): 2,796 (derivative) @ $0EDGAR
2023-06-234Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2023-05-194Rallybio Corp (RLYB)Grant/award (A): 15,490 (derivative) @ $0EDGAR
2023-04-044Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 18,285 @ $0EDGAR
2023-04-034Iterum Therapeutics plc (ITRM)Option exercise (M): 2,041 @ $0 · Option exercise (M): 2,041 (derivative) @ $0EDGAR
2023-03-274Harpoon Therapeutics, Inc. (HARP)Purchase (P): 10,000 @ $1,000 · Purchase (P): 2,994,305 (derivative)EDGAR
2023-01-054Rallybio Corp (RLYB)Grant/award (A): 11,099 (derivative) @ $0EDGAR
2023-01-044Iterum Therapeutics plc (ITRM)Option exercise (M): 1,197 · Option exercise (M): 1,197 (derivative) @ $0EDGAR
2022-12-284Iterum Therapeutics plc (ITRM)Grant/award (A): 5,479 (derivative) @ $0EDGAR
2022-09-274Iterum Therapeutics plc (ITRM)Grant/award (A): 2,796 (derivative) @ $0EDGAR
2022-06-284Iterum Therapeutics plc (ITRM)Grant/award (A): 30,623 (derivative) @ $0EDGAR
2022-06-244Iterum Therapeutics plc (ITRM)Option exercise (M): 36,798 · Option exercise (M): 36,798 (derivative) @ $0EDGAR
2022-06-244Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 10,167 (derivative) @ $0 · Grant/award (A): 32,142 (derivative) @ $1.40EDGAR
2022-06-174Iterum Therapeutics plc (ITRM)Grant/award (A): 647,059 (derivative) @ $0.01EDGAR
2022-05-264Rallybio Corp (RLYB)Grant/award (A): 13,440 (derivative) @ $0EDGAR
2022-03-294Iterum Therapeutics plc (ITRM)Grant/award (A): 17,955 (derivative) @ $0EDGAR
2022-01-054Rallybio Corp (RLYB)Grant/award (A): 6,242 (derivative) @ $0EDGAR
2021-08-124Harpoon Therapeutics, Inc. (HARP)Purchase (P): 235,294 @ $17EDGAR
2021-08-044Rallybio Corp (RLYB)Other (J): 1,993,911 · Purchase (P): 153,846 @ $13 · Purchase (P): 153,846 @ $13 · Other (J): 1,795,946 (derivative) · Other (J): 8,742,654 (derivative) · Other (J): 2,157,838 (derivative) · +1 moreEDGAR
2021-06-254Iterum Therapeutics plc (ITRM)Grant/award (A): 36,798 (derivative) @ $0EDGAR
2021-05-144/AHarpoon Therapeutics, Inc. (HARP)Grant/award (A): 10,167 (derivative) @ $0 · Grant/award (A): 4,658 (derivative) @ $0EDGAR
2021-05-074Harpoon Therapeutics, Inc. (HARP)Grant/award (A): 10,167 (derivative) @ $0 · Grant/award (A): 4,807 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-01 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1247851 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs